Affiliations
AffiliationsItem in Clipboard
Diabetes is a risk factor for the progression and prognosis of COVID-19Weina Guo et al. Diabetes Metab Res Rev. 2020 Oct.
doi: 10.1002/dmrr.3319. Epub 2020 Apr 7. Authors Weina Guo 1 , Mingyue Li 1 , Yalan Dong 1 , Haifeng Zhou 1 , Zili Zhang 1 , Chunxia Tian 1 , Renjie Qin 1 , Haijun Wang 2 , Yin Shen 2 , Keye Du 2 , Lei Zhao 3 , Heng Fan 1 , Shanshan Luo 4 , Desheng Hu 1 4 AffiliationsItem in Clipboard
AbstractBackgound: To figure out whether diabetes is a risk factor influencing the progression and prognosis of 2019 novel coronavirus disease (COVID-19).
Methods: A total of 174 consecutive patients confirmed with COVID-19 were studied. Demographic data, medical history, symptoms and signs, laboratory findings, chest computed tomography (CT) as well the treatment measures were collected and analysed.
Results: We found that COVID-19 patients without other comorbidities but with diabetes (n = 24) were at higher risk of severe pneumonia, release of tissue injury-related enzymes, excessive uncontrolled inflammation responses and hypercoagulable state associated with dysregulation of glucose metabolism. Furthermore, serum levels of inflammation-related biomarkers such as IL-6, C-reactive protein, serum ferritin and coagulation index, D-dimer, were significantly higher (P < .01) in diabetic patients compared with those without, suggesting that patients with diabetes are more susceptible to an inflammatory storm eventually leading to rapid deterioration of COVID-19.
Conclusions: Our data support the notion that diabetes should be considered as a risk factor for a rapid progression and bad prognosis of COVID-19. More intensive attention should be paid to patients with diabetes, in case of rapid deterioration.
Keywords: COVID-19; diabetes; prognosis.
© 2020 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.
Conflict of interest statementThe authors declare that they do not have any conflict of interest regarding this publication.
FiguresFIGURE 1
CT results of the patients…
FIGURE 1
CT results of the patients with diabetes and patients without diabetes. A. The…
FIGURE 1CT results of the patients with diabetes and patients without diabetes. A. The representative CT images of the patients with diabetes and patients without diabetes. B, The CT score of the patients with diabetes and patients without diabetes. P < .05 was considered statistically significant. CT, computed tomography
FIGURE 2
Biochemical examination results of the…
FIGURE 2
Biochemical examination results of the patients with diabetes and patients without diabetes. P…
FIGURE 2Biochemical examination results of the patients with diabetes and patients without diabetes. P < .05 was considered statistically significant
FIGURE 3
Other laboratory tests of the…
FIGURE 3
Other laboratory tests of the patients with diabetes and patients without diabetes. A,…
FIGURE 3Other laboratory tests of the patients with diabetes and patients without diabetes. A, Blood test results of the patients with diabetes and patients without diabetes. B, Inflammation‐related laboratory results of the patients with diabetes and patients without diabetes. C, Coagulation‐related laboratory results of the patients with diabetes and patient without diabetes. P < .05 was considered statistically significant
Similar articlesBhandari S, Rankawat G, Singh A, Gupta V, Kakkar S. Bhandari S, et al. Int J Diabetes Dev Ctries. 2020 Sep;40(3):340-345. doi: 10.1007/s13410-020-00868-7. Epub 2020 Sep 2. Int J Diabetes Dev Ctries. 2020. PMID: 32905072 Free PMC article.
Shcherbak SG, Anisenkova AY, Mosenko SV, Glotov OS, Chernov AN, Apalko SV, Urazov SP, Garbuzov EY, Khobotnikov DN, Klitsenko OA, Minina EM, Asaulenko ZP. Shcherbak SG, et al. Front Immunol. 2021 Nov 10;12:745515. doi: 10.3389/fimmu.2021.745515. eCollection 2021. Front Immunol. 2021. PMID: 34858403 Free PMC article.
Xie J, Wang Q, Xu Y, Zhang T, Chen L, Zuo X, Liu J, Huang L, Zhan P, Lv T, Song Y. Xie J, et al. Ann Palliat Med. 2021 Feb;10(2):1928-1949. doi: 10.21037/apm-20-1863. Epub 2021 Jan 27. Ann Palliat Med. 2021. PMID: 33548996
Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Henry BM, et al. Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369. Clin Chem Lab Med. 2020. PMID: 32286245 Review.
Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. Grobler C, et al. Int J Mol Sci. 2020 Jul 21;21(14):5168. doi: 10.3390/ijms21145168. Int J Mol Sci. 2020. PMID: 32708334 Free PMC article. Review.
Hamouri S, Samrah SM, Albawaih O, Saleh Z, Smadi MM, Alhazymeh A, Syaj S. Hamouri S, et al. Int J Gen Med. 2021 May 24;14:2017-2032. doi: 10.2147/IJGM.S314155. eCollection 2021. Int J Gen Med. 2021. PMID: 34079341 Free PMC article.
Fadl N, Ali E, Salem TZ. Fadl N, et al. Scand J Immunol. 2021 Jun;93(6):e13039. doi: 10.1111/sji.13039. Epub 2021 Mar 19. Scand J Immunol. 2021. PMID: 33710663 Free PMC article. Review.
Menekli T, Yaprak B, Türeyen A, Şentürk S. Menekli T, et al. Prim Care Diabetes. 2022 Oct;16(5):658-663. doi: 10.1016/j.pcd.2022.08.005. Epub 2022 Aug 15. Prim Care Diabetes. 2022. PMID: 36030171 Free PMC article.
Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A. Puig-Domingo M, et al. Endocrine. 2021 May;72(2):301-316. doi: 10.1007/s12020-021-02734-w. Epub 2021 May 8. Endocrine. 2021. PMID: 33963516 Free PMC article.
Shenoy MT, Mohanty PK, Suganthy K, Manavalan JK, Alexander H. Shenoy MT, et al. EJIFCC. 2022 Aug 8;33(2):131-144. eCollection 2022 Aug. EJIFCC. 2022. PMID: 36313911 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3